• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有证据表明,人类补体第四成分C4A的1105和1106同种型残基不参与酰胺键的形成。

Evidence showing that the 1105 and 1106 isotypic residues of the fourth component of human complement, C4A, are not involved in amide bond formation.

作者信息

Reilly B D, Skanes V M, Levine R P

机构信息

Department of Microbiology, University of New Mexico, School of Medicine, Albuquerque 87131.

出版信息

Mol Immunol. 1994 Jul;31(10):761-9. doi: 10.1016/0161-5890(94)90150-3.

DOI:10.1016/0161-5890(94)90150-3
PMID:7518568
Abstract

Human C4A and C4B have different functions that may stem from their ability to bind hydroxyl or free amino groups on complement activating surfaces. Previous studies suggest that C4B binds to hydroxyl or amino groups whereas C4A binds to free amino groups on acceptor molecules. Comparison of the derived amino acid sequences of C4A and C4B has shown that differences exist between them at positions 1101, 1102, 1105 and 1106. These residues appear to be involved in the binding specificity of C4B. Less is known about the corresponding residues of C4A. It has been suggested that the aspartic acid of C4A at position 1106 is involved in amide bond formation by serving as a catalytic residue for the reaction or by promoting an increased interaction with amino nucleophilic groups. To examine the functional role of residues 1101-1106, we studied the effects of the C4A site-specific antipeptide mAb, AII-1 in assays dependent on the covalent binding properties of C4A; the C4 mediated inhibition of hemolysis and the C4 mediated inhibition of immune precipitation. This study shows that mAb AII-1 has no effect on C4-mediated hemolysis or its ability to inhibit the rate of immune precipitate formation. The lack of interference by AII-1 in these assays could not be explained by low affinity interaction between antibody and C4A showing that mAb AII-1 does not affect the covalent binding activity of C4A. Furthermore, results from epitope mapping studies show that AII-1 binds to Leu1105 and Asp1106 suggesting that these residues are not critical for amide bond formation by C4A.

摘要

人C4A和C4B具有不同的功能,这可能源于它们在补体激活表面结合羟基或游离氨基的能力。先前的研究表明,C4B结合羟基或氨基,而C4A结合受体分子上的游离氨基。C4A和C4B推导的氨基酸序列比较表明,它们在第1101、1102、1105和1106位存在差异。这些残基似乎与C4B的结合特异性有关。关于C4A的相应残基了解较少。有人提出,C4A第1106位的天冬氨酸通过作为反应的催化残基或促进与氨基亲核基团的相互作用增强而参与酰胺键形成。为了研究第1101 - 1106位残基的功能作用,我们在依赖C4A共价结合特性的试验中研究了C4A位点特异性抗肽单克隆抗体AII - 1的作用;C4介导的溶血抑制和C4介导的免疫沉淀抑制。本研究表明,单克隆抗体AII - 1对C4介导的溶血或其抑制免疫沉淀形成速率的能力没有影响。AII - 1在这些试验中缺乏干扰不能用抗体与C4A之间的低亲和力相互作用来解释,这表明单克隆抗体AII - 1不影响C4A的共价结合活性。此外,表位作图研究结果表明,AII - 1结合Leu1105和Asp1106,提示这些残基对C4A形成酰胺键并非关键。

相似文献

1
Evidence showing that the 1105 and 1106 isotypic residues of the fourth component of human complement, C4A, are not involved in amide bond formation.有证据表明,人类补体第四成分C4A的1105和1106同种型残基不参与酰胺键的形成。
Mol Immunol. 1994 Jul;31(10):761-9. doi: 10.1016/0161-5890(94)90150-3.
2
Amino acid residues 1101-1105 of the isotypic region of human C4B is important to the covalent binding activity of complement component C4.人C4B同种型区域的氨基酸残基1101 - 1105对补体成分C4的共价结合活性很重要。
J Immunol. 1991 Nov 1;147(9):3018-23.
3
Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4.人类补体成分C4A和C4B及其小鼠同源物Slp和C4的遗传、结构和功能多样性
Int Immunopharmacol. 2001 Mar;1(3):365-92. doi: 10.1016/s1567-5769(01)00019-4.
4
Monoclonal antipeptide antibodies against amino acid residues 1101-1106 of human C4 distinguish C4A from C4B.
Complement Inflamm. 1991;8(1):33-42. doi: 10.1159/000463175.
5
Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A.单个氨基酸的替换(组氨酸替换为天冬氨酸)可将人补体C4B的功能活性转变为C4A的功能活性。
Proc Natl Acad Sci U S A. 1990 Sep;87(17):6868-72. doi: 10.1073/pnas.87.17.6868.
6
The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.人类补体成分C4的Chido和Rodgers同种型免疫溶血活性差异的分子基础。
J Immunol. 1984 Jun;132(6):3019-27.
7
Covalent binding properties of the C4A and C4B isotypes of the fourth component of human complement on several C1-bearing cell surfaces.人类补体第四成分的C4A和C4B同种型在几种携带C1的细胞表面上的共价结合特性。
J Immunol. 1986 Apr 1;136(7):2542-50.
8
Covalent binding properties of the human complement protein C4 and hydrolysis rate of the internal thioester upon activation.人补体蛋白C4的共价结合特性及激活后内部硫酯的水解速率
Protein Sci. 1993 May;2(5):706-16. doi: 10.1002/pro.5560020502.
9
A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.人类补体成分C4的β链第458位残基上单个精氨酸替换为色氨酸导致同种异型C4A6经典途径C5转化酶活性缺陷。对C4中C5结合位点位置的启示。
J Immunol. 1992 May 1;148(9):2803-11.
10
Two isotypes of human C4, C4A and C4B have different structure and function.人类C4的两种同种型,即C4A和C4B,具有不同的结构和功能。
Complement Inflamm. 1989;6(1):19-26. doi: 10.1159/000463068.

引用本文的文献

1
Quantitative analysis of C4Ab and C4Bb binding to the C3b/C4b receptor (CR1, CD35).C4Ab和C4Bb与C3b/C4b受体(CR1,CD35)结合的定量分析。
Clin Exp Immunol. 1997 Nov;110(2):310-6. doi: 10.1111/j.1365-2249.1997.tb08333.x.